Brind.
  1. A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
  2. Sintx Technologies, led by CTO Ryan Bock, has achieved FDA clearance and collaborated with a research group at Virginia Tech.

Sintx Technologies submitted a 510(k) premarket notification to the FDA on July 22, 2025.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sintx Technologies submitted a 510(k) premarket notification to the FDA on July 22, 2025.

Who's involved

What this event is mainly about
FDA

Keep exploring

Part of

Sintx Technologies, led by CTO Ryan Bock, has achieved FDA clearance and collaborated with a research group at Virginia Tech. All 1 developments

Within A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireSINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices Advanced Material Science Meets Surgical Precision in Groundbreaking New Platform in Reconstructive Foot & Ankle